Post-Market Surveillance With a Novel mHealth Platform


This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after sleeve gastrectomy and catheter-base atrial fibrillation ablation.

Study Start Date

January, 26 2018

Estimated Completion Date

August 2018


  • Device: A mobile health platform

Study ID

Yale University -- 2000021455



Trial ID


Study Type

Observational [Patient Registry]

Trial Phase


Enrollment Quota



Yale University

Inclusion Criteria

  • Age >18
  • English-speaking
  • Planned for either sleeve gastrectomy or catheter-based atrial fibrillation ablation
  • Participant is willing and able to read and sign consent and participate in study
  • Participant has an email account and a mobile device (smartphone or tablet) able to download the necessary applications
  • Participant is willing to use the mobile health platform and syncable devices (e.g. Fitbit Charge 2)
  • Attending bariatric surgeon or electrophysiologist (as appropriate) concurs that patient is a candidate for enrollment

Exclusion Criteria

    Healthy patients Patients who refuse participation




18 Years and older

Accepts Healthy Volunteers


Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Yale New Haven Hospital - New Haven, Connecticut 119.2 miles None None None
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Nilay Shah PhD 507-266-5130 provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.